What is it about?
This was a retrospective study on the use of RiaSTAP or Human Fibrinogen Concentrate (HFC) in pediatric cardiac surgery patients. Our study suggest that the use of HFC reduces the needs for transfusion with cryoprecipitate and fresh frozen plasma.
Featured Image
Why is it important?
Reducing blood loss and transfusion requirements are important goals in pediatric cardiac surgery. We believe RiaSTAP can help to achieve this goal.
Perspectives
We use RiaSTAP now routinely in our pediatric cardiac operating room. It is as effective as cryoprecipitate for fibrinogen supplementation, with a much, much lower risk of blood borne infections and cryoprecipitate-induced hypoglycemia.
Dr. Christopher F Tirotta
Nicklaus Children's Hospital
Read the Original
This page is a summary of: Use of Human Fibrinogen Concentrate in Pediatric Cardiac Surgery Patients, International Journal of Anesthetics and Anesthesiology, December 2015, ClinMed International Library,
DOI: 10.23937/2377-4630/2/4/1037.
You can read the full text:
Contributors
The following have contributed to this page
